Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Days Sales Outstanding : 47.76 (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Days Sales Outstanding?

Integrated Diagnostics Holdings's average Accounts Receivable for the three months ended in Jun. 2023 was $16.2 Mil. Integrated Diagnostics Holdings's Revenue for the three months ended in Jun. 2023 was $31.0 Mil. Hence, Integrated Diagnostics Holdings's Days Sales Outstanding for the three months ended in Jun. 2023 was 47.76.

The historical rank and industry rank for Integrated Diagnostics Holdings's Days Sales Outstanding or its related term are showing as below:

IDGXF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.35 Med: 35.95 Max: 53.65
Current: 44.55

During the past 12 years, Integrated Diagnostics Holdings's highest Days Sales Outstanding was 53.65. The lowest was 24.35. And the median was 35.95.

IDGXF's Days Sales Outstanding is ranked better than
81.9% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32 vs IDGXF: 44.55

Integrated Diagnostics Holdings's Days Sales Outstanding declined from Jun. 2022 (48.98) to Jun. 2023 (47.76).

Integrated Diagnostics Holdings Days Sales Outstanding Historical Data

The historical data trend for Integrated Diagnostics Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Days Sales Outstanding Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

37.59

39.87

24.35

49.46

47.17

Integrated Diagnostics Holdings Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															42.83	50.96	47.93	47.76	-

Competitive Comparison of Integrated Diagnostics Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integrated Diagnostics Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Days Sales Outstanding falls into.

Integrated Diagnostics Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Integrated Diagnostics Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (16.042	+	18.432)	/	2 )	/	133.367	*	365
=	17.237					/	133.367	*	365
=	47.17

Integrated Diagnostics Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (15.18	+	17.237)	/	2 )	/	30.967	*	365 / 4
=	16.2085					/	30.967	*	365 / 4
=	47.76

Integrated Diagnostics Holdings (OTCPK:IDGXF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Integrated Diagnostics Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IDHCl:UK IDHC:UK IDHC.CA:Egypt 8I8:Germany

Address

12 Castle Street, Saint Helier, JEY, JE2 3RT

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN • 09-24-2021